-
1
-
-
0342530626
-
Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response
-
LoBuglio AF, Wheeler RH, Trang J, et al. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Si USA 1989;86:4220-4.
-
(1989)
Proc Natl Acad Si USA
, vol.86
, pp. 4220-4224
-
-
-
2
-
-
0026418194
-
Humanized antibodies for therapy
-
Co MS, Queen C. Humanized antibodies for therapy. Nature 1991;351:501-2.
-
(1991)
Nature
, vol.351
, pp. 501-502
-
-
Co, M.S.1
Queen, C.2
-
3
-
-
0030051756
-
Antisense-oligonucleotide therapy
-
Askari FK, McDonnell WM. Antisense-oligonucleotide therapy. N Engl J Med 1996;334:316-8.
-
(1996)
N Engl J Med
, vol.334
, pp. 316-318
-
-
Askari, F.K.1
McDonnell, W.M.2
-
4
-
-
0026575548
-
Somatic gene therapy in gastroenterology: Approaches and applications
-
Ledley FD. Somatic gene therapy in gastroenterology: approaches and applications. J Pediatr Gastroenterol Nutr 1992;14:328-37.
-
(1992)
J Pediatr Gastroenterol Nutr
, vol.14
, pp. 328-337
-
-
Ledley, F.D.1
-
5
-
-
0028003794
-
The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 trangenic rats
-
Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 trangenic rats. J Exp Med 1994;180: 2359-64.
-
(1994)
J Exp Med
, vol.180
, pp. 2359-2364
-
-
Taurog, J.D.1
Richardson, J.A.2
Croft, J.T.3
-
6
-
-
0027369395
-
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
-
Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
-
(1993)
Cell
, vol.75
, pp. 253-261
-
-
Sadlack, B.1
Merz, H.2
Schorle, H.3
Schimpl, A.4
Feller, A.C.5
Horak, I.6
-
7
-
-
0028316255
-
Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes
-
Nicolle MW, Nag B, Sharma SD, et al. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J Clin Invest 1994;93:1361-9.
-
(1994)
J Clin Invest
, vol.93
, pp. 1361-1369
-
-
Nicolle, M.W.1
Nag, B.2
Sharma, S.D.3
-
8
-
-
0028143458
-
Rat intestinal epithelial cells present major histocompatibility complex allopeptides to primed T cells
-
Brandeis JM, Sayegh MH, Gallon L, Blumberg RS, Carpenter CS. Rat intestinal epithelial cells present major histocompatibility complex allopeptides to primed T cells. Gastroenterology 1994;107:1537-42.
-
(1994)
Gastroenterology
, vol.107
, pp. 1537-1542
-
-
Brandeis, J.M.1
Sayegh, M.H.2
Gallon, L.3
Blumberg, R.S.4
Carpenter, C.S.5
-
9
-
-
0029927713
-
Immunosuppression through blockade of CD28:B7-mediated costimulatory signals
-
Judge TA, Tang A, Turka LA. Immunosuppression through blockade of CD28:B7-mediated costimulatory signals. Immunol Res 1996:15:38-49.
-
(1996)
Immunol Res
, vol.15
, pp. 38-49
-
-
Judge, T.A.1
Tang, A.2
Turka, L.A.3
-
10
-
-
0028483990
-
Treatment of murine lupus with CTLA4Ig
-
Finck BK, Linsley PS, Wofsy D. Treatment of murine lupus with CTLA4Ig. Science 1994;265:1225-7.
-
(1994)
Science
, vol.265
, pp. 1225-1227
-
-
Finck, B.K.1
Linsley, P.S.2
Wofsy, D.3
|